Scott Caroen

REPLATINUM Phase III Randomized Study: RRx-001 + Platinum Doublet Versus Platinum Doublet in Third-Line Small Cell Lung Cancer

Bryan Oronsky, Tony R. Reid, Christopher Larson et al. · Future Oncology · 2019 · 49 citations

Platinum Doublet, Medicine, Metronomic Therapy +10

Nucleocapsid as a next-generation COVID-19 vaccine candidate

Bryan Oronsky, Christopher Larson, Scott Caroen et al. · International Journal of Infectious Diseases · 2022 · 41 citations · Full text

Vaccination, Spike Protein, Vaccine Development +13

Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development

Bryan Oronsky, Xiaoning Guo, Xiaohui Wang et al. · Journal of Medicinal Chemistry · 2021 · 39 citations

Tumor Targeted Cytotoxicity, Immunology, Pathology +20

Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial

Michelle M. Kim, Hemant Parmar, Yue Cao et al. · Translational Oncology · 2016 · 31 citations · Full text

Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells

Bryan Oronsky, Tony R. Reid, Arnold L. Oronsky et al. · Oncotarget · 2018 · 22 citations · Full text